How to Report Side Effects Healthcare professionals, patients and caregivers are encouraged to report any suspected adverse reactions to semaglutide, including NAION, via the MHRA Yellow Card scheme: Online at MHRA Yellow Card Reporting, if you are in the United Kingdom Online at FDA MedWatch if you are in the United States Via the Yellow Card app, available on the Apple App Store and Google Play Store Via the NowPatient app When reporting, provide as much information as possible, including medical history, any other medications being taken, when symptoms started and treatment dates
Transparency score: 35/100
Ekstrapolacja profili PK/PD na jakiekolwiek zastosowanie u ludzi wymaga ostronoci i jest sprzeczna z ram Research Use Only
Humans have not shown the same risk, but people with a family history of thyroid cancer or MEN 2 (a rare condition) should avoid these drugs
9 Still, the early evidence suggests semaglutide may be particularly beneficial for people with MS